Abbott Laboratories (ABT) Declares $0.63 Quarterly Dividend, 409th Consecutive Payout
- Abbott Laboratories declared a $0.63 quarterly dividend payable May 15, 2026; record date April 15, 2026.
- It is Abbott’s 409th consecutive quarterly dividend and continues 54 years of annual dividend increases.
- Abbott says dividends signal financial stability and are part of a capital-return program alongside R&D and global commercialization.
Abbott reaffirms century-long dividend cadence
Abbott Laboratories declares a quarterly common dividend of $0.63 per share, payable May 15, 2026, to shareholders of record at the close of business on April 15, 2026, the company says from Abbott Park, Illinois. The payment marks the company's 409th consecutive quarterly dividend since it began quarterly payouts in 1924 and continues a streak of annual dividend increases for 54 consecutive years. Abbott frames the move as part of a sustained capital-return program that coexists with its investment in product and technology development across healthcare sectors.
Company executives position the declaration as a signal of financial stability and long-term commitment to stakeholders while underscoring that dividend continuity is only one element of a broader strategy. Abbott highlights that maintaining regular cash returns complements its work advancing diagnostics, medical devices, nutritionals and branded generic medicines. The board action arrives as Abbott manages a diversified portfolio aimed at both everyday health needs and advanced clinical care, with the dividend described as reinforcing confidence in operating cash flow and portfolio resilience.
The declaration also cements Abbott’s standing among companies with long histories of shareholder distributions, qualifying it for indexes that track firms with multi-decade dividend growth records. While the company does not link the payout to any single product line, the announcement reiterates that consistent capital returns are coordinated with ongoing R&D and global commercialization efforts. Abbott’s messaging stresses continuity — a legacy of payouts dating to 1924 — alongside the company’s present-day focus on sustaining innovation across its businesses.
Global reach and workforce
Abbott says it employs about 115,000 people and serves customers in more than 160 countries, positioning its capital-return policy within a large, multinational operating footprint. The firm emphasizes that its diversified businesses provide multiple revenue streams that support both investment in technologies and regular shareholder distributions.
Release mechanics and channels
The dividend declaration is published via PR Newswire from Abbott Park on Feb. 20, 2026, and the company directs interested parties to its corporate website and social channels for the full release and further corporate updates. Administrative details remain a straightforward $0.63 per-share cash dividend, payable May 15, 2026, to holders of record on April 15, 2026.
Related Cashu News

HCA Healthcare Raises $3 Billion in Senior Unsecured Notes to Enhance Financial Flexibility
HCA Healthcare successfully completes a public offering of senior unsecured notes totaling US$3.00 billion. This significant move reflects the company’s commitment to bolstering financial flexibility…

IDEXX Laboratories Board Members Show Confidence Through Stock Option Exercises Amid Market Challenges
IDEXX Laboratories (Ticker: IDXX) demonstrates a strong commitment to its future growth as recent insider stock transactions reflect the confidence of its board members. On May 14, several board membe…

Centene Announces Leadership Changes to Strengthen Medicaid and Medicare Operations
Centene Corporation (Ticker: CNC) announces major leadership shifts aimed at boosting its Medicaid and Medicare sectors. These changes could positively impact the company’s strategic direction and ope…

Accuray Partners with University of Wisconsin to Advance Innovative Cancer Therapy Technologies
Accuray Incorporated (Ticker: ARAY) forges a significant decade-long partnership with the University of Wisconsin School of Medicine and Public Health to revolutionize personalized cancer care through…